Summary
Leukotrienes, products of the 5-lipoxygenase pathway of arachidonic acid metabolism, have been suggested to play a pathogenic role in psoriasis, because of their ability to induce skin inflammation and to stimulate epidermal proliferation. The 15-lipoxygenase product 15-hydroxy-eicosatetraenoic acid (15-HETE) has no proinflammatory capacity. In contrast, it can inhibit the activity of the 5-lipoxygenase. The purpose of the present study was to study the effect of 5-lipoxygenase inhibitors on the formation of 15-HETE by human neutrophils in vitro. Purified neutrophils were incubated with A 23187 (5 μM) and arachidonic acid (25μM) with and without different inhibitors of 5-lipoxygenase activity (RS 43179, benoxaprofen, NDGA, and CP 66248). Methods for identifying eicosanoids included RP-HPLC and radioimmunoassay. Formation of leukotriene B4 was inhibited in a dose-dependent way, which was strongly correlated with a concomitant increase in the formation of 15-HETE (r=0.97, p<0.01). The cyclooxygenase inhibitor indomethacin did not change 15-HETE formation. The stimulation of 15-HETE formation was not associated with cell damage as assessed by LDH release. Furthermore, identical incubations of T lymphocytes, characterized by a low 5-lipoxygenase activity, did not result in increased 15-HETE formation. These results show that inhibition of 5-lipoxygenase activity can lead to increased formation of 15-HETE. Because 15-HETE inhibits formation of 5-LO products, it may amplify the effect of 5-lipoxygenase inhibitors.
Similar content being viewed by others
References
Bauer FW, van de Kerkhof PCM, Maassen-De Grood RM (1986) Epidermal hyperproliferation following the induction of microabscesses by leukotriene B4. Br J Dermatol 114:409–412
Borregaard N, Kragballe K (1980) The role of oxygen in antibody-dependent cytotoxicity mediated by monocytes and neutrophils. J Clin Invest 66:676–684
Brain S, Camp R, Dowd P, Black AK, Greaves M (1984) The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis. J Invest Dermatol 83:70–73
Brain SD, Camp RDR, Black AK, Dowd PM, Greaves MW, Ford-Hutchinson AW (1985) Leukotrienes C4 and D4 in psoriatic skin lesions. Prostaglandins 29:611–619
Camp RDR, Jones RR, Brain S, Woollard P, Greaves M (1984) Production of intraepidermal microabscesses by topical application of leukotriene B4. J Invest Dermatol 82:202–204
Durgaprasadarao A, Lianos EA, Goodwin JS (1986) Arachidonic acid inhibits 5-lipoxygenase of T cells. Biochem Biophys Res Commun 135:670–676
Fogh K, Kiil J, Herlin T, Ternowitz T, Kragballe K (1987) Heterogeneous distribution of lipoxygenase products in psoriatic skin lesions. Arch Dermatol Res 279:504–511
Fogh K, Søgaard H, Herlin T, Kragballe K (1988) Improvement of psoriasis vulgaris after intralesional injections of 15-hydroxy-eicosatetraenoic acid (15-HETE). J Am Acad Dermatol 18:279–285
Goetzl EJ (1981) Selective feedback inhibition of the 5-lipoxygenation of arachidonic acid in human T-lymphocytes. Biochem Biophys Res Commun 104:344–350
Goldyne ME, Burrish GF, Poubelle P, Borgeat P (1984) Arachidonic acid metabolism among human mononuclear leukocytes. J Biol Chem 259:8815–8819
Jensen JR, Cramers M, Thestrup-Pedersen K (1981) Subpopulations of T-lymphocytes and non-specific suppressor cell activity in patients with atopic dermatitis. Clin Exp Immunol 45:118–123
Kragballe K, Herlin T (1983) Benoxaprofen improves psoriasis: a double blind study. Arch Dermatol 119:548–552
Kragballe K, Voorhees JJ (1983) Arachidonic acid and leukotrienes in dermatology. J Invest Dermatol 81:293–296
Kragballe K, Desjarlais L, Voorhees JJ (1986) Leukotrienes B4, C4, and D4 stimulate DNA synthesis in cultured human epidermal keratinocytes. Br J Dermatol 113:42–52
Kragballe K, Pinnamaneni G, Desjarlais L, Duell EA, Voorhees JJ (1986) Dermis derived 15-hydroxy-eicosatetraenoic acid inhibits epidermal 12-lipoxygenase activity. J Invest Dermatol 87:494–498
Kragballe K, Ternowitz T, Fogh K (1987) 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of PMNs. J Invest Dermatol 89:325 (abstract)
de Laclos BF, Braquet P, Borgeat P (1984) Characteristics of leukotriene (LT) and hydroxy eicosatetraenoic acid (HETE) synthesis in human leukocytes in vitro: effect of arachidonic acid concentration. Prostaglandins Leukotrienes Med 13:47–52
Lassus A, Forsström S (1985) A dimethoxynaphthalene derivate (RS-43179 gel) compared with 0.025% flucinolone acetonide gel in the treatment of psoriasis. Br J Dermatol 113:103–106
Levine JD, Lam D, Taiwo YO, Donatoni P, Goetzl EJ (1986) Hyperalgesic properties of 15-lipoxygenase products of arachidonic acid. Proc Natl Acad Sci USA 83:5331–5334
Luderer JR, Riley DL, Demers M (1983) Rapid extraction of arachidonic acid metabolites using octadecyl reverse phase columns. J Chromatogr 273:402–409
McGuire J, McGee J, Crittenden N, Fitzpatrick F (1985) Cell damage unmasks 15-lipoxygenase activity in human neutrophils. J Biol Chem 260:8316–8319
Miyazawa K, Iimori Y, Makino M, Mikima T, Miyasaka K (1985) Effect of some non-steroidal anti-inflammatory drugs and other agents on cyclooxygenase and lipoxygenase activities in some enzyme preparations. Jpn J Pharmacol 38:199–205
Morita E, Schröder J-M, Christophers E (1987) Studies on arachidonate 15-lipoxygenase activities of human eosinophils and neutrophils. J Invest Dermatol 89:325 (abstract)
Shak S, Perez D, Goldstein IM (1983) A novel dioxygenation product of arachidonic acid possesses potent chemotactic activity for human polymorphonuclear leukocytes. J Biol Chem 258:14948–14953
Sigal E, Grunberger D, Cashman JR, Craik CS, Caughey GH, Nadel JA (1988) Arachidonate 15-lipoxygenase from human eosinophil-enriched leukocytes: partial purification and properties. Biochem Biophys Res Commun 150:376–383
Soter NA, Lewis RA, Corey EJ, Austen KF (1983) Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J Invest Dermatol 80:115–119
Turk J, Maas RL, Brash AR, Roberts J, Oates JA (1982) Arachidonic acid 15-lipoxygenase products from human eosinophils. J Biol Chem 257:7068–7076
Vanderhoek JY, Bryant RW, Bailey JM (1980) Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid. J Biol Chem 255:10064–10066
Vanderhoek JY, Ekborg SL, Baily JM (1984) Nonsteroidal anti-inflammatory drugs stimulate 15-lipoxygenase/leukotriene pathway in human polymorphonuclear leukocytes. J Allergy Clin Immunol 74:412–417
Vanderhoek JY, Karmin HT, Ekborg SL (1985) Endogenous hydroxyeicosatetraenoic acids stimulate the polymorphonuclear leukocyte 15-lipoxygenase pathway. J Biol Chem 260:14482–14487
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fogh, K., Herlin, T. & Kragballe, K. In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils. Arch Dermatol Res 280, 430–436 (1988). https://doi.org/10.1007/BF00429983
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00429983